Search
Breakthrough as new drug promises to shield child cancer patients from hearing loss
- OPACC
- Sep 13, 2023
- 1 min read
A new study, which is to be presented to the RNID Hearing Therapeutics Summit, found that a drug called Pedmark, also known as Pedmarqsi, lowers the risk of hearing loss brought on by cisplatin chemotherapy.
Recent Posts
See AllQuality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...
Commentaires